MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

$FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma$

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

Galderma’s Relfydess™ (RelabotulinumtoxinA) receives positive decision for use in Europe

Rein Therapeutics announces the initiation of the RENEW Phase 2 trial of LTI-03 in patients with IPF

12 May 2025

Rein Therapeutics a biopharmaceutical company advancing a novel pipeline of first-in-class...

Avanzanite Bioscience has appointed a new Chief Financial Officer

SystImmune secures FDA clearance for BL-M17D1 IND in advanced solid tumors

PureWay and PPSWG Form New Partnership to Transform Pharmaceutical Waste Management in the U.S.

NurtureBio Launched Breast Milk–Inspired Synbiotic to Help Babies with Gut Issues

Beauty Crush Skincare Introduces a New Standard in Regenerative Biotech Skincare

By Beauty Crush Skincare
Beauty Crush Skincare
04 Jun 2026

Brain Navi’s KrystoLens Receives TFDA Certification and Is Set to Enter the Taiwan Market

By Brain Navi Biotechnology
Brain Navi Biotechnology
04 Jun 2026

SK bioscience Improves Vaccine Access by Securing Its First UNICEF Procurement Contract

By SK bioscience
SK bioscience
03 Jun 2026

ChromaDex Renames Its External Research Program to the Niagen Research Program, Strengthening Niagen Bioscience's Position as the Global Leader in NAD+ Science

By Niagen Bioscience, Inc
Niagen Bioscience, Inc
03 Jun 2026

AddiVance Offers a Drug-Free Option for Daily Focus, Attention, and Cognitive Support for Families

By Medella Springs
Medella Springs
02 Jun 2026

Seegene Expands Its AMR Testing Portfolio in Europe with the Launch of the Allplex™ MDRO Assay Under IVDR

By Seegene
Seegene
02 Jun 2026

The Digital Pharma Advances Conference 2026

Most Popular

Cold Box Express, Inc. Introduces Refreshed Brand

By Cold Box Express, Inc

Apr 29
Swiss startup Enzian Pharmaceutics is developing a new tablet aimed at enhancing effectiveness and reducing side effects in cancer therapies

By Enzian Pharmaceutics

Sep 17
Fast-Acting Covalent Protein Drugs Developed from a New High-Throughput Platform

By Westlake University

Apr 05

June 2026

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

Search your requirement

Social media

MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

Galderma’s Relfydess™ (RelabotulinumtoxinA) receives positive decision for use in Europe

Rein Therapeutics announces the initiation of the RENEW Phase 2 trial of LTI-03 in patients with IPF

Avanzanite Bioscience has appointed a new Chief Financial Officer

SystImmune secures FDA clearance for BL-M17D1 IND in advanced solid tumors

PureWay and PPSWG Form New Partnership to Transform Pharmaceutical Waste Management in the U.S.

NurtureBio Launched Breast Milk–Inspired Synbiotic to Help Babies with Gut Issues

Beauty Crush Skincare Introduces a New Standard in Regenerative Biotech Skincare

Brain Navi’s KrystoLens Receives TFDA Certification and Is Set to Enter the Taiwan Market

SK bioscience Improves Vaccine Access by Securing Its First UNICEF Procurement Contract

ChromaDex Renames Its External Research Program to the Niagen Research Program, Strengthening Niagen Bioscience's Position as the Global Leader in NAD+ Science

AddiVance Offers a Drug-Free Option for Daily Focus, Attention, and Cognitive Support for Families

Seegene Expands Its AMR Testing Portfolio in Europe with the Launch of the Allplex™ MDRO Assay Under IVDR

Most Popular

Cold Box Express, Inc. Introduces Refreshed Brand

Swiss startup Enzian Pharmaceutics is developing a new tablet aimed at enhancing effectiveness and reducing side effects in cancer therapies

Fast-Acting Covalent Protein Drugs Developed from a New High-Throughput Platform

User Area

Discover

Engage with Us

Search your requirement

Social media

Featured Press Releases

Most Popular

User Area

Discover

Engage with Us

Subscribe to Our Monthly Newsletter